SB Life Science Equity Management, LLC
is led by Dr. Toshihiro Nakada and Mr. Joseph Chow
Mr. Chow was formerly President of Singapore Bio-Innovations, a life sciences-focused venture capital fund set up by the Singapore government in 1990.
has over ten years of venture capital experience in the biotech industry.
notable early-stage investments while at Singapore Bio-Innovations
included Affymetrix, Tularik, Aclara, Lynx, Dendreon, Tanox, Combichem, Therion, Metrika, and ISTA.
Mr. Chow has been an active board member of Optimer Pharmaceuticals, geneticXchange and U-Systems and board observer of Kadmus Pharmaceuticals.
Mr. Chow completed his undergraduate studies at U.C. Berkeley and received a M.Sc. in biochemical engineering from M.I.T. as well as an M.B.A. in finance from the M.I.T. Sloan School of Management.